TrialGene therapy2000
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma.
R Rampling et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
257 papers cite itlatest 60 shown
this paperpooled ittrialcites it